N/A N=69 Anterior Bridging Cage With Bone Substitute Versus Localized Autobone in Transforaminal Lumbar Interbody Arthrodesis
Stenosis · Fusion of Spine (Disease)
Primary: InCBB of Both Cages — 1.48; 1.43 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=160 Metoclopramide for Post Traumatic Headache
Post-Traumatic Headache
Primary: 0-10 Pain Scale on Which 0 = no Pain and 10= the Worst Pain Imaginable — 5.2; 3.8 units on a scale
Phase 2 N=66 Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia
Acute Leukemia
Primary: Number of Participants With Proven/Probable/Possible Invasive Fungal Infection — 1; 0; 2; 62 Participants
N/A N=140 Evaluating a Family-based Nutrition and Garden Intervention in Rural Guatemala
Malnutrition · Dietary Modification
Primary: Change From Baseline in Mean Number of Food Groups Consumed Per Day at 6 Months - Child — 0.6; 1.29 food groups
Phase 1 N=9 A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Primary: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 1 Participants
N/A N=460 An Intervention Study to Reduce Drug-related Problems and Readmissions Among Old People With Dementia
Cognitive Impairment
Primary: Number of Patients Readmitted Because of Drug Related Reasons — 40; 50 Participants
Phase 4 N=5,276 Tailored Antiplatelet Therapy Following PCI
Coronary Artery Disease · Acute Coronary Syndrome · Stenosis
Primary: Occurrence of the a Major Adverse Cardiovascular Event in Subjects Identified as CPY2C19 LOF Carriers by TaqMan. — 35; 54 Participants
Phase 2 N=43 Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
Squamous Non-Small Cell Lung Cancer
Primary: Percentage of Participants With Confirmed Best Objective Response (BOR) According to Response Evaluation Criteria In Solid Tumors (RECIST) Version 1.1 Assessed by…
N/A N=33 Community Pharmacists Vaccinate Against Cancer
Human Papillomavirus Vaccines
Primary: Number of Participants Who Completed HPV Vaccine Series(Preliminary Efficacy) — 8; 11 Participants
Phase 3 N=363 Autologous Transplant for Multiple Myeloma
Multiple Myeloma
Primary: Number of Participants Achieving a Complete Response — 51 Participants
N/A N=23 PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
Intrauterine Adhesion
Primary: Safety (Adverse Events) — 0 device related adverse event
Phase 1 N=7 Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer
Breast Cancer
Primary: Minimum Number of Vaccine Doses Created Using Participant Tumor Sample — 6 doses
N/A N=17 Clinical Algorithm for Post-Stroke Gait Training With C-Brace
Hemiparesis Due to Stroke · Hemiplegia Due to Stroke
Primary: Gait Quality as Indicated by Joint Excursion as Assessed by Kinematic Analysis — 33.98; 9.34; 21.25; 34.51 degrees
Phase 3 N=132 Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery
Urinary Retention · Lower Urinary Tract Symptoms · Stress Urinary Incontinence
Primary: Postoperative Urinary Retention — 16; 5 Participants
Phase 2 N=22 A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Primary: Percentage Able to Complete Full Course of Preoperative Chemotherapy — 22 Participants